Barbara Ryan

INKT

Barbara Ryan serves as director at MiNK Therapeutics, Inc. (INKT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

4 trades

$38.7K

Total Sells

2 trades

$33.4K

Net Position

Net Buyer

$5.3K

Companies Traded

INKT, INDV, IVF

Active Period

Jun 2022 – Jun 2026

6 total trades

Most Recent

Sell INKT

Jun 5, 2026 · $19.1K

Barbara Ryan's Insider Trading at MiNK Therapeutics, Inc. (INKT)

Buys

0 · $0.00

Sells

2 · $33.4K

Total Shares Bought

Total Shares Sold

2,500

INKT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 5, 2026	Sell	1,500	$12.76	$19.1K	22,969
Mar 11, 2026	Sell	1,000	$14.27	$14.3K	21,706

Barbara Ryan's Insider Trading at Indivior Pharmaceuticals Inc (INDV)

Buys

3 · $28.7K

Sells

0 · $0.00

Total Shares Bought

814

Total Shares Sold

INDV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 13, 2026	Buy	8	$31.08	$248.68	5,724
Mar 11, 2026	Buy	31	$32.56	$1.0K	5,716
Jan 5, 2026	Buy	775	$35.39	$27.4K	0

Barbara Ryan's Insider Trading at INVO Fertility, Inc. (IVF)

Buys

1 · $10.0K

Sells

0 · $0.00

Total Shares Bought

10,526

Total Shares Sold

IVF Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 3, 2022	Buy	10,526	$0.95	$10.0K	22,991

Related Insiders

Woodrow D Anderson

officer: Chief Accounting Officer

INDVBuy · Aug 27, 2026

Christian Heidbreder

officer: Chief Scientific Officer

INDVSell · Jul 13, 2026

Ryan Preblick

officer: Chief Financial Officer

INDVSell · Jun 10, 2026

Stuart A Kingsley

director

INDVBuy · Mar 11, 2026

David E. Wheadon

Director

INDVBuy · Jan 5, 2026

Matthew K Szot

Director

IVFSell · Dec 3, 2025

Explore More Insider Trading Data

INKT Insider Trading Activity

View all insider trades at MiNK Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity